Hayashi, Naoki http://orcid.org/0000-0001-8779-3610
Lai, Yong
Fuerte-Stone, Jay http://orcid.org/0000-0001-6991-4183
Mimee, Mark http://orcid.org/0000-0002-3083-2671
Lu, Timothy K.
Funding for this research was provided by:
National Science Foundation (NSF-CCF-1521925)
U.S. Department of Health & Human Services | National Institutes of Health (NIH-5-U01-CA2550554-02, NIH-50000655-5500001351, 5R25GM109439-07, T32 GM007183)
U.S. Department of Health & Human Services | National Institutes of Health
JSR Corporation
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM147478)
Arnold and Mabel Beckman Foundation
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 7 November 2021
Accepted: 7 February 2024
First Online: 7 March 2024
Competing interests
: T.K.L. is a co-founder of Senti Biosciences, Synlogic, Engine Biosciences, Tango Therapeutics, Corvium, BiomX, Eligo Biosciences, Bota.Bio, and Avendesora. T.K.L. also holds financial interests in nest.bio, Ampliphi, IndieBio, MedicusTek, Quark Biosciences, Personal Genomics, Thryve, Lexent Bio, MitoLab, Vulcan, Serotiny, and Avendesora. N.H. is an employee of JSR Corporation. Other authors declare no competing interests.